FIELD: medicine. SUBSTANCE: method involves determining t(9,22)(q34, q11) translocation chromosomes type. Chymeric b3a2 transcript being detected, alpha-interferon treatment of chronic myeloleukemia patients is to be indicated. EFFECT: enhanced accuracy of the method.
Authors
Dates
2001-06-20—Published
2000-10-31—Filed